Personalized Brain Stimulation to Help Veterans Quit Smoking
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Charleston, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 56 people, planned
- Started
- 1 Jul 2026
- Expected to end
- 31 Aug 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transcranial Magnetic Stimulation
- Personalized-image-guided and E-field-modeling dose rTMS (precision TMS)
- Record updated
- 4 August 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Veteran
- Individuals who smoke 10 or more cigarettes per day and have a CO level > 10 ppm indicative of recent smoking
- Those who have not received substance abuse treatment within the previous 30 days
- Those who have been stable on psychotropic medications for at least three months
- For females, those who test non-pregnant and use adequate birth control
- Those who are willing to provide informed consent
- Those who can comply with protocol requirements and likely complete all study procedures
- Those who are motivated to quit smoking (based on responses of "very likely" or "somewhat likely" in the motivation questionnaire
Who cannot take part
- Contraindications to rTMS (history of a seizure or epilepsy)
- A history of autoimmune, endocrine, viral, or vascular disorders affecting the brain
- History or MRI evidence of neurological disorder that would lead to local or diffuse brain lesions or significant physical impairment
- Unstable cardiac disease, uncontrolled hypertension, severe renal or liver insufficiency, or sleep apnea
- Major Axis I disorders diagnosed according to DSM-V criteria, such as bipolar affective disorder, schizophrenia, dementia, or major depression; Regarding the Veteran population, the investigators will enroll smokers who have PTSD
- Current moderate to severe substance use of any psychoactive substances other than nicotine or caffeine, as defined by DSM-V criteria
- Contraindications to MRI (e.g., metal in the skull, orbital or intracranial cavity, or claustrophobia)
- Current use of other forms of nicotine delivery, such as nicotine patches or electronic cigarettes
- Currently prescribed bupropion and/or varenicline
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
This trial is currently available in United States.
- Ralph H. Johnson VA Medical Center, Charleston, SCCharleston, United StatesContact: R. Amanda C LaRue, PhDTaking people
About the trial
What the trial wants to find out
Cigarette smoking is a significant public health concern for Veterans. Encouraging smoking cessation continues to be a top priority for the Veterans' Administration as Veterans who use tobacco experience negative health effects, including cancer, heart disease, and mental disorders. Despite the efficacy of current evidence-based pharmacotherapies and psychotherapies for smoking cessation, alternative treatments are critically needed. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive form of brain stimulation, US FDA-approved for smoking cessation. In this protocol, the investigators propose comparing the two rTMS protocols (standard TMS vs. precision TMS) to find a better treatment parameter for smoking cessation in Veterans. Identifying an efficacious rTMS protocol would benefit Veterans who want to quit smoking.
The 2 groups in the trial
- Deep rTMSExisting treatment, for comparison
The first group will receive 10 Hz DTMS (standard TMS) with a protocol of 3 seconds on, 15 seconds off, and a total of 1800 pulses/session, lasting 18 minutes, targeting the bilateral insula and lateral prefrontal cortex.
Treatment: Transcranial Magnetic Stimulation
- Precision TMSTreatment being tested
The other group will receive 10 Hz personalized-image-guided and Efield-modeling dose rTMS (precision TMS) with a protocol of 5 seconds on, 10 seconds off, and a total of 3000 pulses/session, lasting 15 minutes, targeting the left dorsolateral prefrontal cortex (DLPFC).
Treatment: Personalized-image-guided and E-field-modeling dose rTMS (precision TMS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Circuity-guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Tobacco Use in Veterans: A Comparison of Insula-rTMS and Prefrontal-rTMS
- Criteria questions
- Built from NCT07050862, who can take part
- Record updated
- 4 August 2026